SELLAS Life Sciences Group Inc

NASDAQ:SLS   4:00:00 PM EDT
1.69
+0.02 (+1.20%)
4:10:31 PM EDT: $1.69 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

SELLAS Life Sciences Group Inc Stock, NASDAQ:SLS

Times Square Tower, 7 Times Square, New York, New York 10026
United States of America
Phone: +1.646.200.5278
Number of Employees: 16
http://www.sellaslifesciences.com

Description

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.